How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?

How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?

Anti-hypertensive medications may affect plasma renin activity and/or plasma aldosterone concentration, misleading the interpretation of the aldosterone-to-renin ratio when screening for primary aldosteronism. The Task Force of Taiwan PA recommends that, when necessary, using α-adrenergic receptor b...

Full description

Bibliographic Details
Main Authors:	Jin-Ying Lu, Yi-Yao Chang, Ting-Wei Lee, Ming-Hsien Wu, Zheng-Wei Chen, Yen-Ta Huang, Tai-Shuan Lai, Leay Kiaw Er, Yen-Hung Lin, Vin-Cent Wu, Hao-Min Cheng, Hsien-Li Kao, Charles Jia-Yin Hou, Kwan-Dun Wu, Szu-Tah Chen, Feng-Hsuan Liu
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Journal of the Formosan Medical Association
Subjects:	Primary aldosteronism Aldosterone-to-renin ratio Anti-hypertensive medications α-adrenergic receptor blocking agents Centrally acting α-adrenergic agonists Nondihydropyridine calcium channel blockers
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664623001900

Similar Items

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01)

Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
by: Chin-Chen Chang, et al.
Published: (2021-01-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism
by: Chung-Yi Cheng, et al.
Published: (2021-12-01)

Diagnosis and management of primary aldosteronism
by: Leticia A. P. Vilela, et al.

Mutation in Aldosterone Producing Adenoma
by: Jian-Jhong Wang, et al.
Published: (2017-09-01)

Comparison between screening for primary aldosteronism with and without drug adjustment
by: Yanlong Hua, et al.
Published: (2024-12-01)

Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trialResearch in context
by: Paolo Mulatero, et al.
Published: (2024-05-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

Recurrence of primary aldosteronism after percutaneous ethanol injection
by: Fan-Chi Chang, et al.
Published: (2012-03-01)

Primary Aldosteronism and Cerebrovascular Diseases
by: Zheng-Wei Chen, et al.
Published: (2018-11-01)

Cutoff Values of Aldosterone and the Aldosterone–Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study
by: João Vicente da Silveira, et al.
Published: (2024-09-01)

Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
by: Adina F. Turcu, et al.
Published: (2022-07-01)

Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism
by: Yu-Cheng Lu, et al.
Published: (2023-05-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
by: N.D. Filipets, et al.
Published: (2019-02-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

PSEUDOHYPOALDOSTERONISM
by: A. Rabbani., et al.
Published: (1996-12-01)

PSEUDOHYPOALDOSTERONISM
by: A. Rabbani., et al.
Published: (1996-07-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism
by: Victor Jing-Wei Kang, et al.
Published: (2023-08-01)

Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
by: Jung Hee Kim, et al.
Published: (2016-06-01)

Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1‐7)/MAS receptor axes in human mesangial cells
by: Danielle Stoll, et al.
Published: (2019-06-01)

Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow‐Up Study With Tissue Doppler Imaging
by: Yi‐Yao Chang, et al.
Published: (2019-11-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Impact of Tamsulosin, Tolterodine and drug-combination on the outcomes of lower urinary tract symptoms secondary to post-ureteroscopy ureteral stent: A prospective randomized controlled clinical study
by: O. Abdelkader, et al.
Published: (2017-03-01)

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
by: Alessandro Cannavo, et al.
Published: (2019-08-01)

Alpha adrenergic receptors are involved in the contractile activity of neuropeptide Y in the porcine isolated ovarian artery
by: W. Markiewicz
Published: (2003-10-01)

Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension
by: Dien Yan, et al.
Published: (2024-04-01)

Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
by: Preaw Suwannasrisuk, et al.
Published: (2020-04-01)

Primary aldosteronism: current diagnostic approach
by: Elena S. Eniseeva
Published: (2022-12-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock
by: Kyung Soo Chung, et al.
Published: (2017-05-01)